Yahoo Web Search

Search results

1. • UnitedCFX.com - Trusted Partner in Automated AI Trading

     Digital Journal· 2 days ago

     ...Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June...

2. • PharmaNest to Present Seven Digital Pathology and AI Communications and Abstracts at the...

     Digital Journal· 2 days ago

     ...Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June...

3. • A Bird’s Eye View of the Tumor Microenvironment

     The Scientist· 2 days ago

     The tumor microenvironment is a battleground where infiltrating immune cells either subdue or promote a cancer, all while cancer cells try to dampen the body’s defenses.1,2 Scientists have studied ...

4. • 

     Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion...

     Char-Koosta News· 3 days ago

     Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...

5. • Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead...

     Benzinga· 2 days ago

     Strasbourg, France, June 3, 2024, 7:30 a.m. CET – Transgene TNG, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer today announces that the ...

6. • CHECKPOINT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit...

     Benzinga· 4 days ago

     Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Checkpoint Therapeutics, Inc. ("Checkpoint ...

7. • CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab,...

     Benzinga· 3 days ago

     EMA CHMP recommendation is based on the results of a Phase 3 clinical trial (GEMSTONE-302) demonstrating significant progression-free survival (PFS) and overall survival (OS) benefits of sugemalimab ...

8. • Small Business - Cordele Dispatch | Cordele Dispatch

     Cordele Dispatch· 7 days ago

     Dermatology Specialists of Florida is excited to announce the opening of a new clinic in Niceville, Florida, bringing comprehensive dermatology services to the Okaloosa County community. This ...

9. • Small Business - The Brewton Standard | The Brewton Standard

     The Brewton Standard· 4 days ago

     Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered ...